Metastatic Breast Cancer: Next Generation Sequencing Oncochip

We are studying a new sequencing tool to help decide the best treatment for metastatic breast cancer patients. The goal is to see if it improves survival and response compared to standard chemotherapy.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Casodex
Casodex is a medicine used to treat prostate cancer by blocking male hormones that help the cancer grow.
Olapine
Olapine is a medicine used to treat schizophrenia and bipolar disorder, helping control symptoms like hallucinations, delusions, and extreme mood changes.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Bicalutamide
Bicalutamide is a substance that blocks male hormones to slow the growth of prostate cancer.
Olanzapine
Olanzapine is a substance used to treat schizophrenia and bipolar disorder by helping reduce psychotic symptoms and stabilize mood.
Olaparib
Olaparib is a substance used to treat certain cancers by blocking a DNA-repair protein so cancer cells cannot fix damage and die.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Aedon
Almus
Androbloc

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Istituto Europeo Di Oncologia S.r.l.
Division of Early Drug Development for Innovative Therapies
Opera, Italy
Sponsor: Istituto Europeo Di Oncologia S.r.l.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.